Skip to main content

Randall T. Peterson Lab

The Peterson lab screens using living zebrafish, ensuring that the drug candidates discovered are active in vivo.

Welcome

Researchers in the Peterson lab utilize high-throughout screening technologies to discover new drug candidates for cardiovascular, nervous system, and metabolic disorders. Unlike conventional drug discovery programs that utilize simplified, in vitro assays, the Peterson lab screens using living zebrafish, ensuring that the drug candidates discovered are active in vivo. Several compounds discovered in the lab have not only become widely used research tools, but also preclinical drug candidates.

 

RESEARCH

WATCH PETERSON'S LAB VIDEO

Please click on this image to be taken to be taken to the lab video.

Lab Members

Randall T. Peterson, PhD

Randy received his PhD from Harvard University after studying as a Howard Hughes Medical Institute predoctoral fellow in the laboratory of Professor Stuart L. Schreiber. Following graduation, he completed a postdoctoral fellowship with Professor Mark Fishman at Massachusetts General Hospital. Dr. Peterson then went on to spend 14 years as a faculty member at Harvard University, where he was an Associate Professor of Medicine at Harvard Medical School, an Associate Biologist at Massachusetts General Hospital, and a Senior Associate Member of the Broad Institute. In January of 2017, he arrived at the University of Utah as L.S. Skaggs Presidential Endowed Professor and Dean of the College of Pharmacy.

Orlando Antelope

Orlando Antelope

Orlando received his BS in Cell and Molecular Biology from the University of Utah. He joined the Peterson lab in 2021 after completing his first year as a Bioscience PhD student in the Molecular Biology program. Orlando is examining the role of E3 ubiquitin ligases during early development in zebrafish using our Multiplexed Intermixed CRISPR Droplet (MIC-Drop) platform. 

Simin Rahimi Aliabadi

Simin Rahimi Aliabadi

Simin received her master’s degree in Human Genetics in Shahid Beheshti University of Medical Sciences. As a master student, she focused her research on the association of single nucleotide genetic variants and the susceptibility to schizophrenia. She joined Peterson lab in 2022 as a PhD student. Simin is interested in the molecular mechanisms underlying the cognitive deficits in neurodevelopmental disorders such as autism and schizophrenia with focus on memory and learning. Currently, she is exploring the mechanisms by which NMDA receptor hypofunction impacts cognitive performance.

Emily G. Tippetts

Emily G. Tippetts

Emily received her BS in Cell and Molecular Biology from University of Utah in 2019. She joined the lab in 2020 after completing her first year as a Bioscience PhD student in the Biological Chemistry program. Emily is studying the role of redox balance in cyanide toxicity and mitochondrial disease. She is also using zebrafish models of mitochondrial disease to screen for new therapies.

Contact Us

For more information about the Peterson lab, please contact us at:

Randall T. Peterson

randall.peterson@pharm.utah.edu